Friday – Basic Science Track 1B Survey

Name Badge ID(Required)

Full Name(Required)

Enter your first and last names as you would like them to appear on your certificates.

First Last

Email(Required)

Enter the email you used to register for TOXINS 2022.

Please evaluate the speakers

Overall Evaluation

Topic and Speaker(s)

	Excellent	Good	Fair	Poor
Laboratory confirmation during a large cross-border outbreak of iatrogenic botulism in Europe in 2023 Martin Dorner, PhD (Germany)
Detection of active BoNTs by EndoPep-MS: Is it feasible in standard microbiology laboratories? Ilenia Drigo, PhD (Italy)
X-BAT: Research on and generation of a decavalent equine antitoxin counteracting deliberate botulinum neurotoxin attacks Emmanuel Lemichez, PhD (France)
Botulinum toxin type A antinociceptive activity in spinal cord and trigeminal sensory nociceptive nuclei involves central trans-synaptic transport Dalia Nemanić, MB (Croatia)
Facial neuromuscular junctions and selected brainstem nuclei are the targets of tetanus neurotoxin in cephalic tetanus Federico Fabris, PhD (Italy)

Presentation free of commercial bias?

	Yes	No
Laboratory confirmation during a large cross-border outbreak of iatrogenic botulism in Europe in 2023 Martin Dorner, PhD (Germany)
Detection of active BoNTs by EndoPep-MS: Is it feasible in standard microbiology laboratories? Ilenia Drigo, PhD (Italy)
X-BAT: Research on and generation of a decavalent equine antitoxin counteracting deliberate botulinum neurotoxin attacks Emmanuel Lemichez, PhD (France)
Botulinum toxin type A antinociceptive activity in spinal cord and trigeminal sensory nociceptive nuclei involves central trans-synaptic transport Dalia Nemanić, MB (Croatia)
Facial neuromuscular junctions and selected brainstem nuclei are the targets of tetanus neurotoxin in cephalic tetanus Federico Fabris, PhD (Italy)

If you answered “No, this presentation was not free of commercial bias”, on any of the above, please explain your reason(s).

Applicable to my practice/research

	Yes	No
Laboratory confirmation during a large cross-border outbreak of iatrogenic botulism in Europe in 2023 Martin Dorner, PhD (Germany)
Detection of active BoNTs by EndoPep-MS: Is it feasible in standard microbiology laboratories? Ilenia Drigo, PhD (Italy)
X-BAT: Research on and generation of a decavalent equine antitoxin counteracting deliberate botulinum neurotoxin attacks Emmanuel Lemichez, PhD (France)
Botulinum toxin type A antinociceptive activity in spinal cord and trigeminal sensory nociceptive nuclei involves central trans-synaptic transport Dalia Nemanić, MB (Croatia)
Facial neuromuscular junctions and selected brainstem nuclei are the targets of tetanus neurotoxin in cephalic tetanus Federico Fabris, PhD (Italy)

This activity should improve my

	Strongly disagree	Disagree	Neutral	Agree	Strongly agree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care

Comments